Valuable guidance for community practice on a life-limiting disease
Editorial     Next

Valuable guidance for community practice on a life-limiting disease

Sue Thomas Associate editor, Primary Health Care

Idiopathic pulmonary fibrosis (IPF) is a life-limiting interstitial lung disease. We are unsure what causes it, there is no cure and patients experience debilitating symptoms and long delays before diagnosis is confirmed. Of the 32,500 people with the disease, 300 people die each year and the quality of palliative and end of life care for these patients varies considerably.

Primary Health Care. 28, 4,5-5. doi: 10.7748/phc.28.4.5.s1

You need a subscription to read the full article